
Case Study
Supply chain improvement utilizing the maturity assessment process

Case study
Maturity framework for sales and operations planning (S&OP) in Cytiva

Case study
Advanta Pure: Improving customers on-time delivery (OTD)
The BioPhorum facilitator(s) will capture the key discussions, proposals and decisions in an Event Report. This report will act as the Minutes of the meeting and will
Our aim is to circulate the Event Report in draft form within six working days of the meeting, to all the participants. A final draft will then be made available to all other workstream reps and Phorum Leaders (L2s).
Circulation to guests will be at the discretion of the facilitator(s) and team.
Photos of presentations must only be taken with the express agreement of their author.
Often discussions in meetings are exploratory and involve testing ideas, solutions and approaches.
We ask that all representatives in the meeting and dialling in respect the unformed state of discussions and agree not to comment on the discussions publicly on social media or report on the discussions on open public channels, during the meeting and until the final draft of the Event Report has been circulated and any messaging and communications strategy of the team has been agreed.
This is not a bar to representatives communicating about the meeting with peers, colleagues and stakeholders in their own organisation, this is very much encouraged
The BioPhorum Operations Group (BioPhorum) facilitates a cross industry collaboration process for Biopharmaceutical developers and manufacturers with the aim of accelerating the rate at which the biopharma industry attains a mature and lean state benefitting patients and stakeholders alike. Collaboration modes include best practice sharing, benchmarking, joint-solution development to common challenges, definition of standards requirements and formation of collective perspectives to mutual opportunities and regulatory guidelines.
Biopharmaceutical developers and manufacturers recognize the legally enforceable duties they have including the responsibility to control the quality of materials from their suppliers. From time to time BioPhorum-facilitated collaboration requires, and benefits from, supplier interaction.
Suppliers are providers of supply chain materials such as chemicals, glass, components, excipients, and media. They are also providers of process equipment such as single use systems, engineering parts and consumables. BioPhorum-facilitated supplier interactions may involve: harmonizing manufacturer requirements and communicating these to suppliers; seeking feedback on proposed standards; gaining opinions and ideas related to business process improvement; use of problem solving tools; and gaining support for new ways of working.
The ultimate goal of the BioPhorum collaboration is to strengthen competition, assure product quality and protect patient supply.
The purpose of this document is to set out the principles and policies that BioPhorum follows to ensure that BioPhorum-facilitated supplier interactions are conducted in the correct and appropriate way to meet all legal and business compliance requirements.
Competition Laws: All supplier interactions will comply with anti trust and competition laws and have regard to BioPhorum’s anti-trust compliance statement
Member responsibilities: Individual biopharma companies are responsible for defining their requirements of suppliers.
Innovation and commercial interests: All supplier interactions will recognise and respect the need for suppliers to innovate and pursue their own commercial interests.
Intellectual Property: All supplier interactions will respect suppliers’ intellectual property rights.
Confidentiality / Non Disclosure: All supplier interactions will take into account, respect and encourage compliance with confidentiality and non-disclosure agreements.
Equal Treatment: All suppliers will be treated equally
Communication: These principles, policies and procedures will be communicated to BioPhorum members and suppliers whenever supplier interactions are planned or are taking place.
BioPhorum responsibilities
The BioPhorum Operations Group (BioPhorum) is a cross industry collaboration with the aim of sharing best practice in the area of Operational Excellence.
Participation in BioPhorum is restricted to authorized member company representatives as described in the Principles of Membership Agreement.
While sharing information is central to the process of this collaboration, it is important to understand what information is appropriate to share. Our companies have a great deal of confidential information and intellectual property that should not be shared within BioPhorum.
This document seeks to guide the reader so that the individuals and companies involved follow the correct code of conduct and problems are avoided.
It is the clear and stated intention of BioPhorum that the Group and its activities are conducted at all times in full compliance with relevant competition/anti-trust rules.
It is the responsibility of every person who participates in a BioPhorum event or sharing activity to make sure they are aware of what information is appropriate to share. Furthermore, all participants are responsible for vetting any information to be shared via their company’s public disclosure review processes and that all information shared is free of any “Confidential” stamps or markings.
The key contact (L2) for each member company should ensure confidentiality and that IP issues are highlighted to their colleagues and all applicable company policies regarding external collaboration and public disclosure are adhered to.
The BioPhorum facilitators are responsible for reminding all participants of their obligations with respect to information sharing.
The following list is representative of the types of disclosures commonly allowed by corporate policies. BioPhorum participants should review their company policies to ensure they are in compliance prior to any disclosures. Information in the following areas is typically allowed:
Sharing information from the following areas is typically prohibited by corporate policies
BioPhorum event participants should direct all questions regarding information disclosure to their L2 BioPhorum representatives or corporate legal departments.
It is the clear policy of BioPhorum that BioPhorum and its members will comply with all relevant anti-trust laws in all relevant jurisdictions.
All BioPhorum meetings and activities shall be conducted to strictly abide by all applicable antitrust laws. Meetings attended by BioPhorum members are not to be used to discuss prices, promotions, refusals to deal, boycotts, terms and conditions of sale, market assignments, confidential business plans or other subjects that could restrain competition.
Anti-trust violations may be alleged on the basis of the mere appearance of unlawful activity. For example, discussion of a sensitive topic, such as price, followed by parallel action by those involved or present at the discussion, may be sufficient to infer price-fixing activity and thus lead to investigations by the relevant authorities.
Criminal prosecution by federal or state authorities is a very real possibility for violations of the antitrust laws. Imprisonment, fines or treble damages may ensue.
BioPhorum, its members and guests must conduct themselves in a manner that avoids even the perception or slightest suspicion that antitrust laws are being violated. Whenever uncertainty exists as to the legality of conduct, obtain legal advice. If, during any meeting, you are uncomfortable with or questions arise regarding the direction of a discussion, stop the discussion, excuse yourself and then promptly consult with counsel.
The antitrust laws do not prohibit all meetings and discussions between competitors, especially when the purpose is to strengthen competition and improve the working and efficiency of the marketplace. It is in this spirit that the BioPhorum conducts its meetings and conferences.
External Link warninng
Please use the form below to register now.